Literature DB >> 22017684

AMPK and mTOR in cellular energy homeostasis and drug targets.

Ken Inoki1, Joungmok Kim, Kun-Liang Guan.   

Abstract

The mammalian target of rapamycin (mTOR) is a central controller of cell growth and proliferation. mTOR forms two distinct complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 is regulated by multiple signals such as growth factors, amino acids, and cellular energy and regulates numerous essential cellular processes including translation, transcription, and autophagy. The AMP-activated protein kinase (AMPK) is a cellular energy sensor and signal transducer that is regulated by a wide array of metabolic stresses. These two pathways serve as a signaling nexus for regulating cellular metabolism, energy homeostasis, and cell growth, and dysregulation of each pathway may contribute to the development of metabolic disorders such as obesity, type 2 diabetes, and cancer. This review focuses on our current understanding of the relationship between AMPK and mTORC1 signaling and discusses their roles in cellular and organismal energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017684     DOI: 10.1146/annurev-pharmtox-010611-134537

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  287 in total

1.  Growth-dependent podocyte failure causes glomerulosclerosis.

Authors:  Akihiro Fukuda; Mahboob A Chowdhury; Madhusudan P Venkatareddy; Su Q Wang; Ryuzoh Nishizono; Tsukasa Suzuki; Larysa T Wickman; Jocelyn E Wiggins; Timothy Muchayi; Diane Fingar; Kerby A Shedden; Ken Inoki; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 10.121

2.  MicroRNA-9 regulates osteoblast differentiation and angiogenesis via the AMPK signaling pathway.

Authors:  Jining Qu; Daigang Lu; Hua Guo; Wusheng Miao; Ge Wu; Meifen Zhou
Journal:  Mol Cell Biochem       Date:  2015-09-10       Impact factor: 3.396

3.  AMPK Inhibition Enhances the Neurotoxicity of Cu(II) in SH-SY5Y Cells.

Authors:  Ai-Ping Lan; Xian-Jia Xiong; Jun Chen; Xi Wang; Zhi-Fang Chai; Yi Hu
Journal:  Neurotox Res       Date:  2016-07-19       Impact factor: 3.911

4.  Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.

Authors:  Hongyu Zhou; Chaowei Shang; Min Wang; Tao Shen; Lingmei Kong; Chunlei Yu; Zhennan Ye; Yan Luo; Lei Liu; Yan Li; Shile Huang
Journal:  Biochem Pharmacol       Date:  2016-07-07       Impact factor: 5.858

Review 5.  The Autophagy Lysosomal Pathway and Neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

6.  Regulation of yeast G protein signaling by the kinases that activate the AMPK homolog Snf1.

Authors:  Sarah T Clement; Gauri Dixit; Henrik G Dohlman
Journal:  Sci Signal       Date:  2013-09-03       Impact factor: 8.192

Review 7.  Role of amino acid transporters in amino acid sensing.

Authors:  Peter M Taylor
Journal:  Am J Clin Nutr       Date:  2013-11-27       Impact factor: 7.045

8.  Two novel STK11 missense mutations induce phosphorylation of S6K and promote cell proliferation in Peutz-Jeghers syndrome.

Authors:  Ran Li; Zhiqing Wang; Shu Liu; Baoping Wu; Di Zeng; Yali Zhang; Lanbo Gong; Feihong Deng; Haoxuan Zheng; Yadong Wang; Chudi Chen; Junsheng Chen; Bo Jiang
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

9.  Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.

Authors:  Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

10.  Inhibition of Autophagy by Captopril Attenuates Prion Peptide-Mediated Neuronal Apoptosis via AMPK Activation.

Authors:  Ji-Hong Moon; Jae-Kyo Jeong; Jeong-Min Hong; Jae-Won Seol; Sang-Youel Park
Journal:  Mol Neurobiol       Date:  2018-10-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.